KR102342193B1 - Curable composition - Google Patents

Abstract

When the cured pattern was formed by the photolithographic method with the conventional curable composition, there existed a problem that the residual film rate of the cured pattern after image development was low. A residual-film rate means the value shown by the following formula (z).
Remaining film ratio (%)=Td/Te×100 (z)
[In formula (z), Td represents the film thickness of the cured pattern, and Te represents the film thickness of the composition layer after light irradiation.]
A curable composition comprising quantum dots, a polymerization initiator and a polymerizable compound, wherein the polymerization initiator comprises at least one selected from the group consisting of an oxime compound, an acylphosphine compound, a triazine compound, and a biimidazole compound.

Description

Curable composition {CURABLE COMPOSITION}

The present invention relates to a curable composition containing quantum dots and a display device.

Patent Document 1 describes a curable composition comprising ultrafine semiconductor particles (quantum dots), a solvent, and a polymerizable monomer.

Japanese Patent Laid-Open No. 10-186426

When a cured pattern was formed by the photolithographic method with the curable composition of patent document 1, there existed a problem that the residual film rate of the cured pattern after image development was low. Here, a cured pattern means that the cured film was formed in a part of a board|substrate. In addition, a residual-film rate means the value shown by the following formula (z).

Remaining film ratio (%)=Td/Te×100 (z)

[In formula (z), Td represents the film thickness of the cured pattern, and Te represents the film thickness of the composition layer after light irradiation.]

The present invention includes the following inventions.

[1] A curable composition comprising quantum dots, a polymerization initiator and a polymerizable compound, wherein the polymerization initiator comprises at least one selected from the group consisting of an oxime compound, an acylphosphine compound, a triazine compound, and a biimidazole compound. composition.

[2] The curable composition according to [1], wherein at least one selected from the group consisting of an oxime compound, an acylphosphine compound, a triazine compound, and a biimidazole compound is a compound having at least two aromatic rings in the molecule.

[3] The curable composition according to [1] or [2], wherein the polymerization initiator contains an oxime compound.

[4] The quantum dot contains at least one selected from the group consisting of a compound of a group 12 element and a group 16 element, a compound of a group 13 element and a group 15 element, and a compound of a group 14 element and a group 16 element [1] The curable composition according to any one of to [3].

[5] The curable composition according to any one of [1] to [4], further comprising a resin.

[6] A cured film formed from the curable composition according to any one of [1] to [5].

[7] A display device comprising the cured film according to [6].

ADVANTAGE OF THE INVENTION According to the curable composition of this invention, a cured pattern can be obtained with a high residual film rate at the time of image development, and the said cured pattern is excellent in the quantum yield when light-emitted.

The curable composition of this invention contains a quantum dot (A), a polymeric compound (B), and a polymerization initiator (C).

<Quantum dot (A)>

Quantum dots are semiconductor microparticles|fine-particles with a particle diameter of about 1 nm - 100 nm, and are microparticles|fine-particles which absorb ultraviolet light or visible light using the band gap of a semiconductor, and emit light.

As quantum dots, CdS, CdSe, CdTe, ZnS, ZnSe, ZnTe, HgS, HgSe, HgTe, CdHgTe, CdSeS, CdSeTe, CdSTe, ZnSeS, ZnSeZnTe, ZnSTe, HgSeZnS, HgSeTe, HgSeS, HgSeTe, , CdHgS, CdHgSe, CdHgTe, HgZnS, HgZnSe, HgZnTe, CdZnSeS, CdZnSeTe, CdZnSTe, CdHgSeS, CdHgSeTe, CdHgSTe, HgZnSeS, HgZnSeTe and HgZnSTe of Group 12 elements, such as Group 16 elements; GaN, GaP, GaAs, AlN, AlP, AlAs, InN, InP, InAs, GaNP, GaNAs, GaPAs, AlNP, AlNAs, AlPAs, InNP, InNAs, InPAs, GaAlNP, GaAlNAs, GaAlPAs, GaInNP, GaInNAs, GaInPAs, InAlNP, compounds of a group 13 element and a group 15 element such as InAlNAs and InAlPAs; and compounds of Group 14 elements and Group 16 elements, such as PdS and PbSe.

When a quantum dot contains S (sulfur atom) or Se (selene atom), you may use the quantum dot surface-modified with the metal oxide or organic substance. By using the surface-modified quantum dots, it is possible to prevent S or Se from being extracted by the reactive components in the material forming the organic layer.

Moreover, a quantum dot may combine said compound and may form a core-shell structure. Examples of such a combination include fine particles having a core of CdSe (cadmium selenide) and a shell of ZnS (zinc sulfide).

Since the energy state of a quantum dot depends on its size, the emission wavelength can be freely selected by changing the particle diameter. For example, in the case of quantum dots composed of only CdSe, the peak wavelengths of the fluorescence spectrum when the particle diameters are 2.3 nm, 3.0 nm, 3.8 nm, and 4.6 nm are 528 nm, 570 nm, 592 nm, and 637 nm, respectively. In addition, the light emitted from the quantum dots has a narrow spectral width, and by combining light having such a steep peak, the displayable color gamut of the display device is expanded. In addition, quantum dots have high responsiveness, so that light emitted from a light source can be efficiently used.

The curable composition of this invention may contain only the quantum dot which emits light of a specific wavelength with the light radiated|emitted from a light source, and may contain it in combination of 2 or more types of quantum dots which emit light of a different wavelength. As light of the said specific wavelength, red light, green light, and blue light are mentioned, for example.

It is preferable that the content rate of a quantum dot (A) is 1-50 mass % with respect to solid content, More preferably, it is 5-40 mass %. Solid content as used in this specification means the sum total of the curable composition component except the solvent (E) mentioned later and another solvent. The content rate of solid content in a composition can be measured by well-known analytical means, such as liquid chromatography or gas chromatography.

<Polymerizable compound (B)>

A polymerizable compound (B) is a compound which can superpose|polymerize by the active radical which generate|occur|produced from the polymerization initiator (C) mentioned later, an acid, etc. As such a compound, the compound etc. which have an ethylenically unsaturated bond are mentioned, for example, Preferably it is a (meth)acrylic acid ester compound.

In addition, in this specification, "(meth)acrylic acid" shows at least 1 sort(s) chosen from the group which consists of acrylic acid and methacrylic acid. Notations, such as "(meth)acryloyl" and "(meth)acrylate", also have the same meaning.

Especially, it is preferable that a polymeric compound (B) is a polymeric compound which has 3 or more of ethylenically unsaturated bonds. Examples of the polymerizable compound include trimethylolpropane tri(meth)acrylate, pentaerythritol tri(meth)acrylate, pentaerythritol tetra(meth)acrylate, dipentaerythritol penta(meth)acrylate, dipenta Erythritol hexa (meth) acrylate, tripentaerythritol octa (meth) acrylate, tripentaerythritol hepta (meth) acrylate, tetrapentaerythritol deca (meth) acrylate, tetrapentaerythritol nona (meth) acrylate, tris ( 2-(meth)acryloyloxyethyl)isocyanurate, ethylene glycol modified pentaerythritol tetra(meth)acrylate, ethylene glycol modified dipentaerythritol hexa(meth)acrylate, propylene glycol modified pentaerythritol tetra(meth) Acrylate, propylene glycol modified dipentaerythritol hexa(meth)acrylate, caprolactone modified pentaerythritol tetra(meth)acrylate, caprolactone modified dipentaerythritol hexa(meth)acrylate, etc. are mentioned.

The weight average molecular weight of a polymeric compound (B) becomes like this. Preferably it is 150-2,900, More preferably, it is 250-1,500.

It is preferable that content rate of a polymeric compound (B) is 7-65 mass % with respect to solid content, More preferably, it is 13-60 mass %, More preferably, it is 17-55 mass %. When the content rate of a polymeric compound (B) exists in the said range, there exists a tendency for the residual-film rate of a cured pattern and chemical-resistance of a cured pattern to improve more.

<Polymerization Initiator (C)>

The polymerization initiator (C) is a compound capable of initiating a polymerization reaction by generating an active radical, an acid, etc. by the action of light or heat, and is an oxime compound, a biimidazole compound, a triazine compound, and an acylphosphine compound. It contains at least one selected from the group consisting of. Especially, it is preferable that an oxime compound is included. When these polymerization initiators are used, the residual film rate of a hardening pattern becomes high.

In addition, the above oxime compound, biimidazole compound, triazine compound, and acylphosphine compound are compounds having at least two aromatic rings in the molecule because the degree of polymerization at the time of producing a cured film tends to be higher. it is preferable

As said aromatic ring, 5-membered rings, such as a furan ring, a pyrrole ring, an imidazole ring, a thiophene ring, and a thiazole ring, 6-membered rings, such as a benzene ring, a pyridine ring, a pyrimidine ring, and a triazine ring, and these condensed rings are mentioned. have.

The said oxime compound becomes like this. Preferably, it is an O- acyl oxime compound, It is a compound which has a partial structure represented by Formula (d1). Hereinafter, * represents a bond.

Examples of the oxime compound include N-benzoyloxy-1-(4-phenylsulfanylphenyl)butan-1-one-2-imine, N-benzoyloxy-1-(4-phenylsulfanylphenyl)octane -1-one-2-imine, N-benzoyloxy-1-(4-phenylsulfanylphenyl)-3-cyclopentylpropan-1-one-2-imine, N-acetoxy-1-[9-ethyl -6-(2-methylbenzoyl)-9H-carbazol-3-yl]ethane-1-imine, N-acetoxy-1-[9-ethyl-6-{2-methyl-4-(3,3) -Dimethyl-2,4-dioxacyclopentanylmethyloxy)benzoyl}-9H-carbazol-3-yl]ethane-1-imine, N-acetoxy-1-[9-ethyl-6-(2-methyl) Benzoyl)-9H-carbazol-3-yl]-3-cyclopentylpropan-1-imine, N-benzoyloxy-1-[9-ethyl-6-(2-methylbenzoyl)-9H-carbazole-3 -yl]-3-cyclopentylpropan-1-one-2-imine; The compounds of Unexamined-Japanese-Patent No. 2011-132215, International Publication No. 2008/78678, International Publication No. 2008/78686, and International Publication No. 2012/132558, etc. are mentioned. You may use commercial items, such as Irgacure OXE01, OXE02 (above, BASF company make), and N-1919 (made by ADEKA company).

Among them, the oxime compound is N-benzoyloxy-1-(4-phenylsulfanylphenyl)butan-1-one-2-imine, N-benzoyloxy-1-(4-phenylsulfanylphenyl)octane-1 -one-2-imine, N-benzoyloxy-1-(4-phenylsulfanylphenyl)-3-cyclopentylpropan-1-one-2-imine and N-acetoxy-1-[9-ethyl-6 At least one selected from the group consisting of -(2-methylbenzoyl)-9H-carbazol-3-yl]ethane-1-imine is preferable, and N-benzoyloxy-1-(4-phenylsulfanylphenyl)octane More preferred is -1-one-2-imine and/or N-acetoxy-1-[9-ethyl-6-(2-methylbenzoyl)-9H-carbazol-3-yl]ethan-1-imine. .

The said biimidazole compound is a compound represented by Formula (d5), for example.

[In formula (d5), R ⁵¹ to R ⁵⁶ represent an optionally substituted C6-C10 aryl group.]

Examples of the aryl group having 6 to 10 carbon atoms include a phenyl group, a toluyl group, a xylyl group, an ethylphenyl group and a naphthyl group, and a phenyl group is preferable.

As a substituent, a halogen atom, a C1-C4 alkoxy group, etc. are mentioned, for example. As a halogen atom, a fluorine atom, a chlorine atom, a bromine atom, an iodine atom etc. are mentioned, for example, Preferably it is a chlorine atom. As a C1-C4 alkoxy group, a methoxy group, an ethoxy group, a propoxy group, a butoxy group etc. are mentioned, for example, Preferably it is a methoxy group.

Examples of the biimidazole compound include 2,2'-bis(2-chlorophenyl)-4,4',5,5'-tetraphenylbiimidazole and 2,2'-bis(2-chlorophenyl). Phenyl)-4,4',5,5'-tetraphenyl-1,2'-biimidazole, 2,2'-bis(2,3-dichlorophenyl)-4,4',5,5'- tetraphenylbiimidazole, 2,2'-bis(2-chlorophenyl)-4,4',5,5'-tetraphenylbiimidazole, 2,2'-bis(2-chlorophenyl)-4, 4',5,5'-tetra(alkoxyphenyl)biimidazole, 2,2'-bis(2-chlorophenyl)-4,4',5,5'-tetra(dialkoxyphenyl)biimidazole, 2,2'-bis(2-chlorophenyl)-4,4',5,5'-tetra(trialkoxyphenyl)biimidazole, the phenyl group at the 4,4'5,5'-position is a carboalkoxy group and imidazole compounds substituted by These compounds are, for example, in Japanese Patent Application Laid-Open No. Hei 06-75372, Japanese Patent Application Laid-Open No. Hei 06-75373, Japanese Unexamined Patent Application Laid-Open No. 48-38403, and Japanese Patent Application Laid-Open No. 62-174204. It is described in Japanese Patent Application Laid-Open No. 7-10913, and the like. Especially, the compound represented by the following formula or these mixtures are preferable.

Examples of the triazine compound include 2,4-bis(trichloromethyl)-6-(4-methoxyphenyl)-1,3,5-triazine, 2,4-bis(trichloromethyl) -6- (4-methoxynaphthyl) -1,3,5-triazine, 2,4-bis (trichloromethyl) -6-piperonyl-1,3,5-triazine, 2,4 -Bis(trichloromethyl)-6-(4-methoxystyryl)-1,3,5-triazine, 2,4-bis(trichloromethyl)-6-[2-(5-methylfuran-) 2-yl)ethenyl]-1,3,5-triazine, 2,4-bis(trichloromethyl)-6-[2-(furan-2-yl)ethenyl]-1,3,5- Triazine, 2,4-bis(trichloromethyl)-6-[2-(4-diethylamino-2-methylphenyl)ethenyl]-1,3,5-triazine, 2,4-bis(trichloro and romethyl)-6-[2-(3,4-dimethoxyphenyl)ethenyl]-1,3,5-triazine. Among them, 2,4-bis(trichloromethyl)-6-piperonyl-1,3,5-triazine is preferable.

Examples of the acylphosphine compound include bis(2,4,6-trimethylbenzoyl)-phenylphosphine oxide and (2,4,6-trimethylbenzoyl)diphenylphosphine oxide.

The above-mentioned polymerization initiator may be used independently and may use two or more polymerization initiators together. When using two or more polymerization initiators together, you may combine with well-known polymerization initiators other than the above-mentioned oxime compound, a biimidazole compound, a triazine compound, and an acylphosphine compound.

As a combination of two or more polymerization initiators, the compound of the same kind from which a structure differs may be combined, and the compound of a different kind may be combined. When combining a compound of the same kind, the combination of oxime compounds is preferable, and the combination of the compounds which have the partial structure shown by Formula (d1) as an O-acyl oxime compound is more preferable. Examples of such combinations include N-benzoyloxy-1-(4-phenylsulfanylphenyl)octan-1-one-2-imine and N-acetoxy-1-[9-ethyl-6-(2-methylbenzoyl) A combination of -9H-carbazol-3-yl]ethan-1-imine is mentioned. In this case, N-benzoyloxy-1-(4-phenylsulfanylphenyl)octan-1-one-2-imine and N-acetoxy-1-[9-ethyl-6-(2-methylbenzoyl)-9H It is preferable that the compounding ratio of -carbazol-3-yl]ethane-1-imine is 10:90-90:10, It is more preferable that it is 30:70-70:30, It is 30:70-50:50 it is more preferable

As a combination of different types of compounds, an oxime compound and a biimidazole compound, an oxime compound and a triazine compound, an oxime compound and an acylphosphine compound, a biimidazole compound and a triazine compound, a biimidazole compound and an acylphosphine compound, tri The combination of an azine compound and an acylphosphine compound, etc. are mentioned.

As a well-known polymerization initiator, Benzoin compounds, such as benzoin, benzoin methyl ether, benzoin ethyl ether, benzoin isopropyl ether, and benzoin isobutyl ether; Benzophenone, o-benzoyl methyl benzoate, 4-phenylbenzophenone, 4-benzoyl-4'-methyldiphenyl sulfide, 3,3' 4,4'-tetra (tert-butylperoxycarbonyl) benzophenone, benzophenone compounds such as 2,4,6-trimethylbenzophenone and 4,4'-bis(diethylamino)benzophenone; quinone compounds such as 9,10-phenanthrenequinone, 2-ethylanthraquinone and camphorquinone; 10-butyl-2-chloroacridone, benzyl, methyl phenylglyoxylate, titanocene compound, etc. are mentioned.

To [ content of a polymerization initiator (C) / 100 mass parts of polymeric compound (B)), Preferably it is 0.1-300 mass parts, More preferably, it is 0.1-200 mass parts. When a curable composition contains resin (D) mentioned later, content of a polymerization initiator (C) becomes like this with respect to 100 mass parts of total amounts of resin (D) mentioned later and a polymeric compound (B), Preferably 0.1-30 It is a mass part, More preferably, it is 1-20 mass parts. When content of a polymerization initiator (C) exists in the said range, since there exists a tendency for it to become highly sensitive and exposure time to shorten, productivity of a cured film improves.

<Polymerization initiation aid (C1)>

If necessary, you may use together a polymerization initiation adjuvant (C1). A polymerization initiation adjuvant (C1) is a compound used in order to accelerate|stimulate superposition|polymerization of the polymeric compound which superposition|polymerization was started by a polymerization initiator, or a sensitizer. When a polymerization initiation adjuvant (C1) is included, it is used in combination with a polymerization initiator normally. As polymerization initiation adjuvant (C1), an amine compound, an alkoxy anthracene compound, a thioxanthone compound, a carboxylic acid compound, etc. are mentioned.

Examples of the amine compound include triethanolamine, methyldiethanolamine, triisopropanolamine, methyl 4-dimethylaminobenzoate, ethyl 4-dimethylaminobenzoate, isoamyl 4-dimethylaminobenzoate, 2-dimethylaminoethyl benzoate, and 4-dimethylamino 2-ethylhexyl benzoate, N,N-dimethylparatoluidine, 4,4'-bis(dimethylamino)benzophenone (commonly known as Michler's ketone), 4,4'-bis(diethylamino)benzophenone, 4,4 '-bis(ethylmethylamino)benzophenone etc. are mentioned, Especially, 4,4'-bis(diethylamino)benzophenone is preferable. You may use commercial items, such as EAB-F (made by Hodogaya Chemical Industry Co., Ltd.).

Examples of the alkoxyanthracene compound include 9,10-dimethoxyanthracene, 2-ethyl-9,10-dimethoxyanthracene, 9,10-diethoxyanthracene, 2-ethyl-9,10-diethoxyanthracene, and 9,10- Dibutoxy anthracene, 2-ethyl-9, 10- dibutoxy anthracene, etc. are mentioned.

Examples of the thioxanthone compound include 2-isopropylthioxanthone, 4-isopropylthioxanthone, 2,4-diethylthioxanthone, 2,4-dichlorothioxanthone, and 1-chloro-4-propoxy. City oxanthon etc. are mentioned.

Examples of the carboxylic acid compound include phenylsulfanylacetic acid, methylphenylsulfanylacetic acid, ethylphenylsulfanylacetic acid, methylethylphenylsulfanylacetic acid, dimethylphenylsulfanylacetic acid, methoxyphenylsulfanylacetic acid, dimethoxyphenylsulfanylacetic acid, chloro and phenylsulfanylacetic acid, dichlorophenylsulfanylacetic acid, N-phenylglycine, phenoxyacetic acid, naphthylthioacetic acid, N-naphthylglycine, and naphthoxyacetic acid.

When a polymerization initiation adjuvant (C1) is included, content of a polymerization initiation adjuvant (C1) becomes like this with respect to 100 mass parts of polymeric compound (B), Preferably it is 0.1-300 mass parts, More preferably, it is 0.1-200 mass parts. is the mass part. When a curable composition contains resin (D) mentioned later, content of a polymerization initiator (C) becomes like this with respect to 100 mass parts of total amounts of resin (D) and a polymeric compound (B), Preferably 0.1-30 mass parts , More preferably, it is 1-20 mass parts. When the amount of the polymerization start adjuvant (C1) is within this range, there is a tendency that a cured film can be formed more highly sensitively.

It is preferable that the curable composition of this invention contains resin (D), a solvent (E), and/or a leveling agent (F) other than the above-mentioned component.

<Resin (D)>

It is preferable that resin (D) is alkali-soluble resin. As resin (D), the following resins [K1] - [K4] are mentioned, for example.

Resin [K1]: at least one selected from the group consisting of unsaturated carboxylic acid and unsaturated carboxylic acid anhydride (a) (hereinafter sometimes referred to as “(a)”), and a monomer copolymerizable with (a) (c) (However, it is different from (a). Hereinafter, it may be referred to as "(c)") a copolymerized resin;

Resin [K2]: Monomer (b) having a cyclic ether structure having 2 to 4 carbon atoms and an ethylenically unsaturated bond in the copolymer of (a) and (c) (hereinafter referred to as “(b)” resins reacted with),

Resin [K3]: a resin obtained by reacting (a) with the copolymer of (b) and (c);

Resin [K4]: Resin in which (a) was made to react with the copolymer of (b) and (c), and also carboxylic acid anhydride was reacted.

As (a), For example, unsaturated monocarboxylic acids, such as acrylic acid, methacrylic acid, a crotonic acid, o-, m-, p-vinyl benzoic acid;

Maleic acid, fumaric acid, citraconic acid, mesaconic acid, itaconic acid, 3-vinylphthalic acid, 4-vinylphthalic acid, 3,4,5,6-tetrahydrophthalic acid, 1,2,3,6-tetrahydrophthalic acid, dimethyl unsaturated dicarboxylic acids such as tetrahydrophthalic acid and 1,4-cyclohexenedicarboxylic acid;

Methyl-5-norbornene-2,3-dicarboxylic acid, 5-carboxybicyclo[2.2.1]hept-2-ene, 5,6-dicarboxybicyclo[2.2.1]hept-2-ene , 5-Carboxy-5-methylbicyclo[2.2.1]hept-2-ene, 5-carboxy-5-ethylbicyclo[2.2.1]hept-2-ene, 5-carboxy-6-methylbicyclo Bicyclo unsaturated compounds containing a carboxy group, such as [2.2.1]hept-2-ene and 5-carboxy-6-ethylbicyclo[2.2.1]hept-2-ene;

Maleic anhydride, citraconic anhydride, itaconic anhydride, 3-vinylphthalic anhydride, 4-vinylphthalic anhydride, 3,4,5,6-tetrahydrophthalic anhydride, 1,2,3,6-tetrahydrophthalic anhydride , unsaturated dicarboxylic acid anhydrides such as dimethyltetrahydrophthalic anhydride and 5,6-dicarboxybicyclo[2.2.1]hept-2-ene anhydride;

Unsaturated mono [(meth) acryloyloxyalkyl] of polyhydric carboxylic acids with divalent or higher valence, such as succinic acid mono [2- (meth) acryloyloxyethyl] and phthalic acid mono [2- (meth) acryloyloxyethyl] esters;

and unsaturated acrylates containing a hydroxyl group and a carboxyl group in the same molecule, such as α-(hydroxymethyl)acrylic acid.

Among these, acrylic acid, methacrylic acid, maleic anhydride, etc. are preferable from the point of copolymerization reactivity and the solubility point with respect to the aqueous alkali solution of resin obtained.

(b) has, for example, a cyclic ether structure having 2 to 4 carbon atoms (eg, at least one selected from the group consisting of an oxirane ring, an oxetane ring and a tetrahydrofuran ring) and an ethylenically unsaturated bond It is a monomer. As for (b), the monomer which has a C2-C4 cyclic ether structure and a (meth)acryloyloxy group is preferable.

As (b), glycidyl (meth)acrylate, β-methylglycidyl (meth)acrylate, β-ethyl glycidyl (meth)acrylate, glycidyl vinyl ether, o-vinylbenzylglycy Dil ether, m-vinylbenzyl glycidyl ether, p-vinylbenzyl glycidyl ether, α-methyl-o-vinylbenzyl glycidyl ether, α-methyl-m-vinylbenzyl glycidyl ether, α-methyl -p-vinylbenzylglycidyl ether, 2,3-bis(glycidyloxymethyl)styrene, 2,4-bis(glycidyloxymethyl)styrene, 2,5-bis(glycidyloxymethyl) Styrene, 2,6-bis(glycidyloxymethyl)styrene, 2,3,4-tris(glycidyloxymethyl)styrene, 2,3,5-tris(glycidyloxymethyl)styrene, 2, an oxirane ring such as 3,6-tris(glycidyloxymethyl)styrene, 3,4,5-tris(glycidyloxymethyl)styrene, and 2,4,6-tris(glycidyloxymethyl)styrene; a monomer having an ethylenically unsaturated bond; 3-methyl-3-methacryloyloxymethyloxetane, 3-methyl-3-acryloyloxymethyloxetane, 3-ethyl-3-methacryloyloxymethyloxetane, 3-ethyl-3- Acryloyloxymethyloxetane, 3-methyl-3-methacryloyloxyethyloxetane, 3-methyl-3-acryloyloxyethyloxetane, 3-ethyl-3-methacryloyloxyethylox Monomers having an oxetane ring and an ethylenically unsaturated bond, such as cetane and 3-ethyl-3-acryloyloxyethyl oxetane; Monomers having a tetrahydrofuran ring and an ethylenically unsaturated bond, such as tetrahydrofurfuryl acrylate (for example, Viscote V#150, manufactured by Osaka Organic Chemical Industry Co., Ltd.) and tetrahydrofurfuryl methacrylate; have.

(b) has high reactivity at the time of production of resins [K2] to [K4], and unreacted (b) hardly remains, as (b), it has an oxirane ring and an ethylenically unsaturated bond Monomers are preferred.

As (c), for example, methyl (meth)acrylate, ethyl (meth)acrylate, n-butyl (meth)acrylate, sec-butyl (meth)acrylate, tert-butyl (meth)acrylate, 2-ethylhexyl (meth) acrylate, dodecyl (meth) acrylate, lauryl (meth) acrylate, stearyl (meth) acrylate, cyclopentyl (meth) acrylate, cyclohexyl (meth) acrylate, 2-methylcyclohexyl (meth) acrylate, tricyclo [5.2.1.0 ^2,6 ] decan-8-yl (meth) acrylate (common in the art: dicyclofentanyl (meth) acrylate or tricyclodecyl (meth)acrylate), tricyclo[5.2.1.0 ^2,6 ]decen-8-yl (meth)acrylate (common name in the art: dicyclopentenyl (meth)acrylate), dicyclopentanyloxyethyl (meth) acrylate, isobornyl (meth) acrylate, adamantyl (meth) acrylate, allyl (meth) acrylate, propargyl (meth) acrylate, phenyl (meth) acrylate, naphthyl ( (meth)acrylic acid esters, such as meth)acrylate and benzyl (meth)acrylate;

hydroxy group-containing (meth)acrylic acid esters such as 2-hydroxyethyl (meth)acrylate and 2-hydroxypropyl (meth)acrylate;

dicarboxylic acid diesters such as diethyl maleate, diethyl fumarate, and diethyl itaconic acid;

Bicyclo[2.2.1]hept-2-ene, 5-methylbicyclo[2.2.1]hept-2-ene, 5-ethylbicyclo[2.2.1]hept-2-ene, 5-hydroxybi Cyclo[2.2.1]hept-2-ene, 5-hydroxymethylbicyclo[2.2.1]hept-2-ene, 5-(2'-hydroxyethyl)bicyclo[2.2.1]hept-2 -ene, 5-methoxybicyclo[2.2.1]hept-2-ene, 5-ethoxybicyclo[2.2.1]hept-2-ene, 5,6-dihydroxybicyclo[2.2.1]hept -2-ene, 5,6-di(hydroxymethyl)bicyclo[2.2.1]hept-2-ene, 5,6-di(2'-hydroxyethyl)bicyclo[2.2.1]hept- 2-ene, 5,6-dimethoxybicyclo[2.2.1]hept-2-ene, 5,6-diethoxybicyclo[2.2.1]hept-2-ene, 5-hydroxy-5-methyl Bicyclo[2.2.1]hept-2-ene, 5-hydroxy-5-ethylbicyclo[2.2.1]hept-2-ene, 5-hydroxymethyl-5-methylbicyclo[2.2.1] Hept-2-ene, 5-tert-butoxycarbonylbicyclo[2.2.1]hept-2-ene, 5-cyclohexyloxycarbonylbicyclo[2.2.1]hept-2-ene, 5-phenoxy Cycarbonylbicyclo[2.2.1]hept-2-ene, 5,6-bis(tert-butoxycarbonyl)bicyclo[2.2.1]hept-2-ene, 5,6-bis(cyclohexylox bicyclo unsaturated compounds such as cycarbonyl)bicyclo[2.2.1]hept-2-ene;

N-phenylmaleimide, N-cyclohexylmaleimide, N-benzylmaleimide, N-succinimidyl-3-maleimidebenzoate, N-succinimidyl-4-maleimidebutylate, N-succinimidyl dicarbonylimide derivatives such as -6-maleimide caproate, N-succinimidyl-3-maleimide propionate, and N-(9-acridinyl) maleimide;

Styrene, α-methylstyrene, m-methylstyrene, p-methylstyrene, vinyltoluene, p-methoxystyrene, acrylonitrile, methacrylonitrile, vinyl chloride, vinylidene chloride, acrylamide, methacrylamide, acetic acid vinyl, 1,3-butadiene, isoprene, 2,3-dimethyl-1,3-butadiene, and the like.

Among these, styrene, vinyltoluene, N-phenylmaleimide, N-cyclohexylmaleimide, N-benzylmaleimide, bicyclo[2.2.1]hept-2-ene, etc. are preferable from the point of copolymerization reactivity and heat resistance. do.

In the resin [K1], the proportion of the structural units derived from each monomer is 2 to 70 mol% of the structural units derived from (a) based on the total structural units constituting the resin [K1], and It is preferable that the structural unit derived from (c) is 30-98 mol%. Moreover, it is more preferable that the structural unit derived from (a) is 10-70 mol%, and it is more preferable that the structural unit derived from (c) is 30-90 mol%.

When the ratio of the structural unit of the resin [K1] is within the above range, it tends to be excellent in storage stability of the curable composition, developability in forming a cured pattern, and solvent resistance of the obtained cured pattern.

Resin [K1] is, for example, the method described in the document "Experimental Method of Polymer Synthesis" (Otsu Takayuki Publishing House, Chemical Dongin, 1st Edition, 1st Edition, March 1, 1972) and citations described in the document It can be prepared with reference to the literature.

Specifically, a predetermined amount of each of (a) and (c), a polymerization initiator and a solvent are put in a reaction vessel, for example, by replacing oxygen with nitrogen to create a deoxidized atmosphere, and heating and keeping warm while stirring method can be found. In addition, the polymerization initiator and solvent used here are not specifically limited, The thing normally used in the said field|area can be used. Examples of the polymerization initiator include azo compounds (2,2'-azobisisobutyronitrile, 2,2'-azobis(2,4-dimethylvaleronitrile), etc.) and organic peroxides (benzoyl peroxide, etc.) ) can be mentioned. As a solvent, what is necessary is just to melt|dissolve each monomer, The solvent etc. which are mentioned later as a solvent (E) which may be contained in the curable composition of this invention are mentioned.

In addition, the obtained copolymer may use the solution after reaction as it is, may use the concentrated or diluted solution, and may use what was taken out as solid (powder) by methods, such as reprecipitation. In particular, by using the solvent (E) described later as the solvent for this polymerization, the solution after the reaction can be used as it is for the preparation of the curable composition of the present invention, so the manufacturing process of the curable composition of the present invention can be simplified. .

Resin [K2] is manufactured by obtaining the copolymer of (a) and (c), and adding the C2-C4 cyclic ether of (b) to the carboxylic acid and/or carboxylic acid anhydride derived from (a). can do.

First, the copolymer of (a) and (c) is produced in the same manner as described as the method for producing the resin [K1]. In this case, it is preferable that the ratio of the structural unit derived from each is the same ratio as what was mentioned in resin [K1].

Next, the C2-C4 cyclic ether which (b) has is added-reacted to a part of the carboxylic acid and/or carboxylic acid anhydride derived from (a) in the said copolymer.

Following the preparation of the copolymer of (a) and (c), the atmosphere in the flask is replaced with air from nitrogen, and (b), a reaction catalyst for the reaction between carboxylic acid or carboxylic acid anhydride and a cyclic ether (e.g., tris ( dimethylaminomethyl)phenol etc.) and a polymerization inhibitor (for example, hydroquinone) etc. are put in a flask, and resin [K2] can be manufactured by making it react at 60-130 degreeC for 1 to 10 hours, for example.

As for the usage-amount of (b), 5-80 mol is preferable with respect to 100 mol of (a), More preferably, it is 10-75 mol. By setting it as this range, there exists a tendency for the balance of storage stability of a curable composition, developability at the time of forming a cured pattern, and solvent resistance, heat resistance, mechanical strength, and sensitivity of the cured pattern obtained to become favorable.

As for the usage-amount of the said reaction catalyst, 0.001-5 mass parts is preferable with respect to 100 mass parts of total amounts of (a), (b), and (c). As for the usage-amount of the said polymerization inhibitor, 0.001-5 mass parts is preferable with respect to 100 mass parts of total amounts of (a), (b), and (c).

Reaction conditions, such as the preparation method, reaction temperature, and time, can be suitably adjusted in consideration of manufacturing equipment, the amount of heat generated by polymerization, and the like. In addition, similarly to polymerization conditions, the preparation method and reaction temperature can be adjusted suitably in consideration of manufacturing equipment, the calorific value by polymerization, etc.

Resin [K3] is a 1st step, it carries out similarly to the manufacturing method of resin [K1] mentioned above, and obtains the copolymer of (b) and (c). Similarly to the above, the obtained copolymer may use the solution after reaction as it is, may use a concentrated or diluted solution, or may use what was taken out as a solid (powder) by methods, such as reprecipitation.

The proportion of the structural units derived from (b) and (c) is 5 to 95 mol% of the structural units derived from (b), respectively, with respect to the total number of moles of all structural units constituting the copolymer, and It is preferable that the structural unit derived from (c) is 5-95 mol%. Moreover, it is more preferable that the structural unit derived from (b) is 10-90 mol%, and it is 10-90 mol% of the structural unit derived from (c).

Further, under the same conditions as in the production method of the resin [K2], the carboxylic acid or carboxylic acid anhydride of (a) is added to the cyclic ether derived from (b) of the copolymer of (b) and (c). By doing so, resin [K3] can be obtained.

As for the usage-amount of (a) made to react with the said copolymer, 5-80 mol is preferable with respect to 100 mol of (b).

Resin [K4] is resin in which carboxylic acid anhydride was further made to react with resin [K3].

A carboxylic acid anhydride is subjected to an addition reaction to a hydroxy group generated by the reaction of a cyclic ether with carboxylic acid or carboxylic acid anhydride.

Examples of the carboxylic anhydride include maleic anhydride, citraconic anhydride, itaconic anhydride, 3-vinyl phthalic anhydride, 4-vinyl phthalic anhydride, 3,4,5,6-tetrahydrophthalic anhydride, 1,2,3,6 -tetrahydrophthalic anhydride, dimethyltetrahydrophthalic anhydride, 5,6-dicarboxybicyclo[2.2.1]hept-2-ene anhydride, etc. are mentioned. As for the usage-amount of carboxylic acid anhydride, 0.5-1 mol is preferable with respect to 1 mol of usage-amounts of (a).

Specific examples of the resin (D) include resins [K1] such as benzyl (meth)acrylate/(meth)acrylic acid copolymer and styrene/(meth)acrylic acid copolymer; Resin obtained by adding glycidyl (meth) acrylate to benzyl (meth) acrylate/(meth) acrylic acid copolymer, glycidyl (meth) to tricyclodecyl (meth) acrylate/styrene/(meth)acrylic acid copolymer ) Resin to which acrylate was added, resin [K2], such as a resin which added glycidyl (meth)acrylate to tricyclodecyl (meth)acrylate/benzyl (meth)acrylate/(meth)acrylic acid copolymer; Tricyclodecyl (meth) acrylate / glycidyl (meth) acrylate copolymer of (meth) acrylic acid reacted, tricyclodecyl (meth) acrylate / styrene / glycidyl (meth) acrylate resin [K3] such as a resin obtained by reacting (meth)acrylic acid with a copolymer; and resins [K4] such as a resin obtained by reacting a copolymer of tricyclodecyl (meth)acrylate/glycidyl (meth)acrylate with (meth)acrylic acid and further reacting with tetrahydrophthalic anhydride. have.

Among these, it is preferable that at least one selected from the group consisting of resin [K2], resin [K3], and resin [K4] is included as the resin (D).

Preferably the weight average molecular weight of polystyrene conversion of resin (D) is 3,000-100,000, More preferably, it is 5,000-50,000, More preferably, it is 5,000-30,000. When the molecular weight is within the above range, the hardness of the cured film is improved, the residual film ratio of the cured pattern is high, the solubility in the developer of the unexposed part in the composition layer is good, and the resolution of the cured pattern tends to be improved.

The molecular weight distribution [weight average molecular weight (Mw)/number average molecular weight (Mn)] of resin (D) becomes like this. Preferably it is 1.1-6, More preferably, it is 1.2-4.

The acid value of resin (D) becomes like this. Preferably it is 50-170 mg-KOH/g, More preferably, it is 60-150 mg-KOH/g, More preferably, it is 70-135 mg-KOH/g. Here, an acid value is a value measured as the quantity (mg) of potassium hydroxide required to neutralize 1 g of resin (D), For example, it can obtain|require by titrating using potassium hydroxide aqueous solution.

To [ content of resin (D) ] with respect to the total amount of solid content, Preferably it is 7-65 mass %, More preferably, it is 13-60 mass %, More preferably, it is 17-55 mass %. When content of resin (D) exists in the said range, there exists a tendency for the resolution of a cured pattern and the residual-film rate of a cured pattern to improve more.

<Solvent (E)>

The solvent (E) will not be specifically limited if it dissolves a polymeric compound (B), a polymerization initiator (C), and resin (D), A solvent normally used in this field|area can be used. For example, ester solvents (solvents containing -COO- in the molecule and not containing -O-), ether solvents (solvents containing -O- in the molecule and not containing -COO-), ether esters Solvents (solvents containing -COO- and -O- in the molecule), ketone solvents (solvents containing -CO- and not containing -COO- in the molecule), alcohol solvents (containing OH in the molecule, - solvents not containing O-, -CO- and -COO-), aromatic hydrocarbon solvents, amide solvents, dimethyl sulfoxide, and the like.

Examples of the ester solvent include methyl lactate, ethyl lactate, n-butyl lactate, methyl 2-hydroxyisobutanoate, ethyl acetate, n-butyl acetate, isobutyl acetate, n-pentyl formate, isopentyl acetate, n-butyl propionate, butyric acid isopropyl, ethyl butyrate, n-butyl butyrate, methyl pyruvate, ethyl pyruvate, propyl pyruvate, methyl acetoacetate, ethyl acetoacetate, cyclohexanol acetate, γ-butyrolactone, and the like.

As the ether solvent, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol monopropyl ether, ethylene glycol monobutyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monobutyl ether, propylene Glycol monomethyl ether, propylene glycol monoethyl ether, propylene glycol monopropyl ether, propylene glycol monobutyl ether, 3-methoxy-1-butanol, 3-methoxy-3-methylbutanol, tetrahydrofuran, tetrahydropyran, 1,4-dioxane, diethylene glycol dimethyl ether, diethylene glycol diethyl ether, diethylene glycol methyl ethyl ether, diethylene glycol dipropyl ether, diethylene glycol dibutyl ether, anisole, phenetol and methylanisole and the like.

Examples of the ether ester solvent include methyl methoxyacetate, ethyl methoxyacetate, butyl methoxyacetate, methyl ethoxyacetate, ethyl ethoxyacetate, methyl 3-methoxypropionate, ethyl 3-methoxypropionate, and methyl 3-ethoxypropionate. , 3-ethoxypropionate ethyl, 2-methoxypropionate methyl, 2-methoxypropionate ethyl, 2-methoxypropionate propyl, 2-ethoxypropionate methyl, 2-ethoxypropionate ethyl, 2-methoxy-2- Methyl methyl propionate, 2-ethoxy-2-methyl ethyl propionate, 3-methoxybutyl acetate, 3-methyl-3-methoxybutyl acetate, propylene glycol monomethyl ether acetate, propylene glycol monoethyl ether acetate, propylene glycol mono and propyl ether acetate, ethylene glycol monomethyl ether acetate, ethylene glycol monoethyl ether acetate, diethylene glycol monoethyl ether acetate, and diethylene glycol monobutyl ether acetate.

As a ketone solvent, 4-hydroxy-4-methyl-2-pentanone, acetone, 2-butanone, 2-heptanone, 3-heptanone, 4-heptanone, 4-methyl-2-pentanone, cyclo pentanone, cyclohexanone, isophorone, and the like.

Examples of the alcohol solvent include methanol, ethanol, propanol, butanol, hexanol, cyclohexanol, ethylene glycol, propylene glycol and glycerin.

Examples of the aromatic hydrocarbon solvent include benzene, toluene, xylene and mesitylene.

Examples of the amide solvent include N,N-dimethylformamide, N,N-dimethylacetamide and N-methylpyrrolidone.

As a solvent, Propylene glycol monomethyl ether acetate, ethyl lactate, propylene glycol monomethyl ether, 3-ethoxy ethyl propionate, ethylene glycol monomethyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, 4-hydroxy -4-methyl-2-pentanone or toluene is preferred.

Preferably the content rate of a solvent (E) is 70-95 mass % with respect to the total amount of curable composition, More preferably, it is 75-92 mass %. In other words, solid content of curable composition becomes like this. Preferably it is 5-30 mass %, More preferably, it is 8-25 mass %. When content of a solvent (E) exists in the said range, the flatness of the composition layer at the time of application|coating becomes more favorable, and there exists a tendency for it easy to form a cured film of an appropriate film thickness.

<Leveling agent (F)>

As a leveling agent (F), silicone type surfactant, the silicone type surfactant etc. which have a silicone type surfactant, a fluorine type surfactant, and a fluorine atom are mentioned. These may have a polymerizable group in a side chain.

As a silicone type surfactant, the surfactant etc. which have a siloxane bond in a molecule|numerator are mentioned. Specifically, Toray Silicon DC3PA, SH7PA, DC11PA, SH21PA, SH28PA, SH29PA, SH30PA, SH8400 (trade name: Toray Dow Corning Co., Ltd.), KP321, KP322, KP323, KP324, KP326, KP340, KP341 (manufactured by Shin-Etsu Chemical Co., Ltd.), TSF400, TSF401, TSF410, TSF4300, TSF4440, TSF4445, TSF4446, TSF4452 and TSF4460 (manufactured by Momentive Performance Materials Japan joint venture), etc. can

As said fluorochemical surfactant, the surfactant etc. which have a fluorocarbon chain in a molecule|numerator are mentioned. Specifically, Fluorad (registered trademark) FC430, copper FC431 (manufactured by Sumitomo Re-M Co., Ltd.), Megapack (registered trademark) F142D, copper F171, copper F172, copper F173, copper F177, copper F183, copper F554, Copper R30, Copper RS-718-K (DIC Co., Ltd.), FTOP (registered trademark) EF301, Copper EF303, Copper EF351, Copper EF352 (Mitsubishi Material Electrochemical Co., Ltd.), Surflon (registered trademark) S381, copper S382, copper SC101, copper SC105 (manufactured by Asahi Glass Co., Ltd.) and E5844 (manufactured by Daikin Fine Chemical Research Institute), etc. are mentioned.

Examples of the silicone-based surfactant having a fluorine atom include a surfactant having a siloxane bond and a fluorocarbon chain in the molecule. Specific examples thereof include Megapack (registered trademark) R08, BL20, F475, F477, and F443 (manufactured by DIC Corporation).

Content of a leveling agent (F) with respect to the total amount of curable composition, Preferably they are 0.001 mass % or more and 0.2 mass % or less, Preferably they are 0.002 mass % or more and 0.1 mass % or less, More preferably, 0.01 mass % or more and 0.05 mass% or less. When content of a leveling agent (F) exists in the said range, the flatness of a cured film can be made more favorable.

In addition, the curable composition of the present invention may further contain additives known in the art, such as fillers, other high molecular compounds, adhesion promoters, antioxidants, light stabilizers, chain transfer agents, and the like, if necessary.

<Cured film>

The cured film of this invention can be obtained by apply|coating the curable composition of this invention to a board|substrate, and hardening it by the action|action of light or a heat|fever. The cured film of this invention may be formed in the said board|substrate whole surface, and may be formed in a part of the said board|substrate (namely, a hardening pattern). As a method of forming a cured film in a part of the said board|substrate, the photolithographic method, the inkjet method, the printing method, etc. are mentioned. Especially, the photolithographic method is preferable. A photolithographic method is a method of apply|coating the curable composition of this invention to a board|substrate, drying as needed, forming a composition layer, exposing the said composition layer through a photomask, and developing.

As a method of forming a cured film on the entire surface of the substrate, the curable composition of the present invention is applied to the substrate, dried as necessary to form a composition layer, and the composition layer is heated and/or exposed to the entire surface of the composition layer. can be heard

Examples of the substrate include a glass plate such as quartz glass, borosilicate glass, alumina silicate glass, and soda-lime glass with a silica-coated surface, a resin plate such as polycarbonate, polymethyl methacrylate, and polyethylene terephthalate, silicon, and aluminum on the substrate , silver, silver/copper/palladium alloy thin films, etc. are formed.

Formation of the hardening pattern by the photolithographic method can be performed by a well-known or customary apparatus and conditions. For example, it can manufacture as follows.

First, a curable composition is apply|coated on a board|substrate, volatile components, such as a solvent, are removed by heat-drying (pre-baking) and/or drying under reduced pressure, and a composition layer is obtained. As a coating method, the spin coating method, the slit coating method, the slit and spin coating method, etc. are mentioned.

30-120 degreeC is preferable and, as for the temperature in the case of heat-drying, 50-110 degreeC is more preferable. Moreover, as heating time, it is preferable that they are 10 second - 60 minutes, and it is more preferable that they are 30 second - 30 minutes.

When drying under reduced pressure, it is preferable to carry out under a pressure of 50 to 150 Pa at a temperature range of 20 to 25°C.

The film thickness of the composition layer is not specifically limited, What is necessary is just to select suitably according to the film thickness of the target hardening pattern.

Next, the composition layer is exposed through the photomask for forming the target hardening pattern. The pattern on the said photomask is not specifically limited.

As a light source used for exposure, the light source which generate|occur|produces the light of the wavelength of 250-450 nm is preferable. For example, according to the absorption wavelength of a polymerization initiator, you may selectively extract the light of 436 nm vicinity, 408 nm vicinity, or 365 nm vicinity from the light of the said wavelength with a band pass filter. Specifically, a mercury lamp, a light emitting diode, a metal halide lamp, a halogen lamp, etc. are mentioned.

It is preferable to use an exposure apparatus such as a mask aligner and a stepper because parallel rays can be uniformly irradiated to the entire exposure surface or the photomask and the substrate on which the composition layer is formed can be precisely aligned. The exposed composition layer is cured by polymerization of a polymerizable compound or the like contained in the composition layer.

By bringing the composition layer after exposure into contact with a developing solution and developing it, the unexposed part of a composition layer melt|dissolves in a developing solution, and is removed, and a hardening pattern is obtained. As a developing solution, the aqueous solution and organic solvent of alkaline compounds, such as potassium hydroxide, sodium hydrogencarbonate, sodium carbonate, and tetramethylammonium hydroxide, are mentioned, for example. The concentration in the aqueous solution of the alkaline compound is preferably 0.01 to 10 mass%, more preferably 0.03 to 5 mass%. As an organic solvent, the thing similar to the solvent (E) mentioned above is mentioned. Moreover, the developing solution may also contain surfactant.

Any of a paddle method, a dipping method, a spray method, etc. may be sufficient as the image development method. Moreover, you may incline a board|substrate at an arbitrary angle at the time of image development.

It is preferable to further heat (post-baking) to the hardening pattern obtained by image development. 150-250 degreeC is preferable and, as for heating temperature, 160-235 degreeC is more preferable. 1 to 120 minutes are preferable and, as for heating time, 10 to 60 minutes are more preferable. By heating after image development, superposition|polymerization of the unreacted polymeric compound contained in a hardening pattern, etc. can advance, and the hardening pattern more excellent in chemical-resistance can be obtained.

By irradiating an ultraviolet light or visible light to a cured film, the cured film of this invention emits light of the wavelength different from irradiation light. The curable composition used when forming the cured film of this invention WHEREIN: The wavelength of the light to emit light can be selected by selecting the component and particle diameter of the quantum dot contained in the said curable composition.

Since the cured film of this invention has a function to convert the wavelength of irradiation light as above-mentioned, it can be used as a color conversion layer of a display device. As such a display device, for example, Unexamined-Japanese-Patent No. 2006-309219, Unexamined-Japanese-Patent No. 2006-310303, Unexamined-Japanese-Patent No. 2013-15812, Unexamined-Japanese-Patent No. 2009-251129, JP The display device described in Unexamined-Japanese-Patent No. 2014-2363 etc. is mentioned.

Since the curable composition of this invention can obtain a cured pattern with a high residual film rate at the time of image development, and the said cured pattern is excellent in the quantum yield when light-emitted, the color conversion layer of a display device, especially a liquid crystal display device useful as

Example

Hereinafter, the present invention will be described in more detail by way of Examples.

Unless otherwise indicated, "%" and "part" in an example are mass % and mass part.

Synthesis Example 1

100 parts of propylene glycol monomethyl ether acetate was put into a flask equipped with a stirring device, a dropping funnel, a condenser, a thermometer, and a gas introduction tube, and it stirred while replacing with nitrogen, and it heated up to 120 degreeC. Next, the polymerization initiator 2,2'-azobis(2,4-dimethylvaleronitrile) was added dropwise to a monomer mixture comprising 40 parts of benzyl methacrylate and 20 parts of methacrylic acid with respect to 100 parts of the monomer mixture. It was dripped at the flask over 2 hours from the funnel, and it stirred at 120 degreeC for 2 hours, and obtained the copolymer solution. Next, the inside of the flask is switched to air substitution, and 10 parts of glycidyl methacrylate, 0.44 parts of triphenylphosphine, and 0.08 parts of methylhydroquinone are added to the copolymer solution, and the reaction is continued at 120°C, and the solid content acid value is 130KOHmg When /g is reached, the reaction is terminated. To this, by adding 80 parts of propylene glycol monomethyl ether acetate, the resin D1 solution of 30% of solid content was obtained. The weight average molecular weight of the resin D1 was 3.0×10 ⁴ .

The measurement of the weight average molecular weight (Mw) of resin was performed on condition of the following by GPC method.

Device; K2479 (manufactured by Shimadzu Corporation)

column; SHIMADZU Shim-pack GPC-80M

column temperature; 40℃

menstruum; tetrahydrofuran

flow rate; 1.0mL/min

detector; RI

calibration standards; TSK STANDARD POLYSTYRENE F-40, F-4, F-288, A-2500, A-500 (manufactured by Toso Corporation)

<Preparation of curable composition>

The following were used for preparation of a curable composition, respectively.

(A) Quantum dots

CZ520: Quantum dots manufactured by NN-LABS, 10% toluene dispersion, core-shell type (core: CdSe, shell: ZnS).

CZ620: Quantum dots manufactured by NN-LABS, 10% toluene dispersion, core-shell type (core: CdSe, shell: ZnS).

(B) polymerizable compound

KAYARAD (registered trademark) DPHA: Nippon Kayaku Co., Ltd. product, dipentaerythritol hexaacrylate.

(C) polymerization initiator

Irgacure (registered trademark) OXE01: An oxime compound manufactured by BASF, N-benzoyloxy-1-(4-phenylsulfanylphenyl)octan-1-one-2-imine.

B-CIM: Biimidazole compound manufactured by Hodogaya Chemical Co., Ltd., 2,2'-bis(2-chlorophenyl)-4,4',5,5'-tetraphenyl-1,2'-biimi Dazole.

Irgacure (trademark) OXE02: oxime compound manufactured by BASF, N-acetoxy-1-[9-ethyl-6-(2-methylbenzoyl)-9H-carbazol-3-yl]ethane-1-imine .

Irgacure (trademark) 819: an acylphosphine compound manufactured by BASF, bis(2,4,6-trimethylbenzoyl)-phenylphosphine oxide.

Triazine PP: A triazine compound manufactured by Panchim, 2,4-bis(trichloromethyl)-6-piperonyl-1,3,5-triazine.

(C1) polymerization initiation aid

EAB-F: Hodogaya Chemical Co., Ltd. product, 4,4'-bis(diethylamino)benzophenone.

(F) leveling agent

Toray Silicone SH8400: A product of Toray Dow Corning Co., Ltd., polyether-modified silicone oil.

[Example 1]

(A) 240 parts of quantum dots "CZ520" and "TO-1382" manufactured by Toa Synthesis Co., Ltd. (a monoester of dipentaerythritol pentaacrylate and succinic acid, dipentaerythritol hexaacrylate and dipentaerythritol pentaacrylic rate mixture) were mixed, and the quantum dots were sufficiently dispersed with a bead mill to prepare a quantum dot dispersion. Subsequently, (B) 40 parts of polymerizable compound "KAYARAD DPHA", (C) 8 parts of polymerization initiator "Irgacure OXE01", (D) 60 parts of Resin D1 as resin (in terms of solid content), (E) As a solvent, 654 parts of propylene glycol monomethyl ether acetate and 0.1 part of (F) leveling agent "Toray Silicone SH8400" were mixed, and the curable composition was obtained.

[Example 2]

(A) 240 parts of quantum dots "CZ520", and 24 parts of "TO-1382" manufactured by Toa Synthesis Co., Ltd. were mixed, and the quantum dots were sufficiently dispersed by a bead mill to prepare a quantum dot dispersion. Subsequently, (B) 40 parts of polymerizable compound "KAYARAD DPHA", (C) 7 parts of polymerization initiator "B-CIM", (C1) 1 part of polymerization initiation auxiliary "EAB-F", (D) resin 60 parts (in terms of solid content) of Resin D1 as (E) 654 parts of propylene glycol monomethyl ether acetate as a solvent and (F) 0.1 parts of a leveling agent "Toray Silicone SH8400" were mixed to obtain a curable composition.

[Example 3]

(A) 240 parts of quantum dots "CZ520", and 24 parts of "TO-1382" manufactured by Toa Synthesis Co., Ltd. were mixed, and the quantum dots were sufficiently dispersed by a bead mill to prepare a quantum dot dispersion. Subsequently, (B) 40 parts of polymerizable compound "KAYARAD DPHA", (C) 8 parts of polymerization initiator "Irgacure 819", (D) 60 parts of resin D1 as resin (in terms of solid content), (E) 654 parts of propylene glycol monomethyl ether acetate as a solvent and 0.1 part of (F) leveling agent "Toray Silicone SH8400" were mixed, and the curable composition was obtained.

[Example 4]

(A) 240 parts of quantum dots "CZ520", and 24 parts of "TO-1382" manufactured by Toa Synthesis Co., Ltd. were mixed, and the quantum dots were sufficiently dispersed by a bead mill to prepare a quantum dot dispersion. Subsequently, (B) 40 parts of polymerizable compound "KAYARAD DPHA", (C) 8 parts of polymerization initiator "Triazine PP", (D) 60 parts of Resin D1 as resin (in terms of solid content), (E) solvent 654 parts of propylene glycol monomethyl ether acetate and (F) leveling agent "Toray Silicone SH8400" were mixed with 0.1 parts to obtain a curable composition.

[Example 5]

(A) 270.7 parts of quantum dots "CZ620", and 24 parts of "TO-1382" manufactured by Toa Synthesis Co., Ltd. were mixed, and the quantum dots were sufficiently dispersed by a bead mill to prepare a quantum dot dispersion. Subsequently, (B) 40 parts of polymerizable compound "KAYARAD DPHA", (C) 8 parts of polymerization initiator "Irgacure OXE01", (D) 60 parts of Resin D1 as resin (in terms of solid content), (E) 393 parts of propylene glycol monomethyl ether acetate as a solvent, and 0.2 part of (F) leveling agent "Toray Silicone SH8400" were mixed, and the curable composition was obtained.

[Example 6]

(C) A curable composition was obtained in the same manner as in Example 5 except that the compounding amount of the polymerization initiator "Irgacure OXE01" was changed to 10 parts.

[Example 7]

(C) A curable composition was obtained in the same manner as in Example 5 except that the compounding quantity of the polymerization initiator "Irgacure OXE01" was changed to 12 parts.

[Example 8]

(C) A curable composition was obtained in the same manner as in Example 5 except that "Irgacure OXE02" was used as a polymerization initiator.

[Example 9]

(C) A curable composition was obtained in the same manner as in Example 8 except that the compounding quantity of the polymerization initiator "Irgacure OXE02" was changed to 10 parts.

[Example 10]

(C) A curable composition was obtained in the same manner as in Example 8 except that the compounding quantity of the polymerization initiator "Irgacure OXE02" was changed to 12 parts.

[Example 11]

(C) A curable composition was obtained in the same manner as in Example 5 except that 12 parts of "Irgacure 819" was mixed as a polymerization initiator.

[Example 12]

(C) As a polymerization initiator, except having mixed 12 parts of "triazine PP", it carried out similarly to Example 5, and obtained the curable composition.

[Example 13]

(C) A curable composition was obtained in the same manner as in Example 5 except that 3.6 parts of "Irgacure OXE01" and 8.4 parts of "Irgacure OXE02" were used as polymerization initiators.

[Example 14]

(C) A curable composition was obtained in the same manner as in Example 13, except that the blending amount of the polymerization initiator “Irgacure OXE01” was changed to 6.0 parts and the blending amount of “Irgacure OXE02” to 6.0 parts, respectively.

[Example 15]

(C) A curable composition was obtained in the same manner as in Example 13 except that the blending amount of the polymerization initiator "Irgacure OXE01" was changed to 8.4 parts and the blending amount of "Irgacure OXE02" to 3.6 parts, respectively.

[Example 16]

(C) A curable composition was obtained in the same manner as in Example 13, except that 6.0 parts of "Irgacure OXE01" and 6.0 parts of "Irgacure 819" were used as polymerization initiators.

[Example 17]

(C) A curable composition was obtained in the same manner as in Example 13, except that 6.0 parts of "Irgacure OXE01" and 6.0 parts of "triazine PP" were used as polymerization initiators.

[Example 18]

(C) A curable composition was obtained in the same manner as in Example 13, except that 6.0 parts of "Irgacure OXE02" and 6.0 parts of "Irgacure 819" were used as polymerization initiators.

[Example 19]

(C) A curable composition was obtained in the same manner as in Example 13 except that 6.0 parts of "Irgacure OXE02" and 6.0 parts of "triazine PP" were used as polymerization initiators.

[Comparative Example 1]

(A) 220 parts of quantum dots "CZ520" and 22 parts of "DISPERBYK-180 (main component: alkylol ammonium salt of copolymer containing an acid group)" manufactured by Big Chemie Japan Co., Ltd. are mixed, and quantum dots are mixed with a bead mill was sufficiently dispersed to prepare a quantum dot dispersion. Subsequently, (B) 100 parts of polymerizable compound "KAYARAD DPHA", (E) 677 parts of propylene glycol monomethyl ether acetate as a solvent, and (F) 0.1 parts of leveling agent "Toray Silicone SH8400" are mixed to form a curable composition got

<Production of cured film>

After apply|coating a curable composition by the spin coating method on a 5 cm horizontal glass substrate (Eagle 2000, the Corning company make), it prebaked at 100 degreeC for 1 minute, and the composition layer was obtained. After allowing to cool, the entire surface of the composition layer was irradiated with light using an exposure machine (TME-150RSK; manufactured by Topcon Co., Ltd.) in an atmospheric atmosphere at ^{an exposure amount of 150 mJ/cm 2 (based on 365 nm).} After light irradiation, it was immersed in an aqueous developer solution (aqueous solution containing 0.12% of a nonionic surfactant and 0.04% of potassium hydroxide) at 23° C. for 60 seconds, washed with water, and post-baked at 200° C. for 10 minutes in an oven. By performing, the cured film was obtained.

<Measurement of film thickness>

The film thickness of the obtained cured film was measured with the film thickness measuring apparatus (DEKTAK3, Nippon Vacuum Technology Co., Ltd. product).

<Measurement of quantum yield ratio>

To the quantum dot dispersion used for preparation of the curable composition, toluene was added so that the absorbance in wavelength 450nm might be set to 0.4, and the diluted dispersion liquid was prepared. About the said diluted dispersion liquid and the cured film obtained above, the quantum yield in excitation wavelength 450nm was measured with the fluorescent quantum yield measuring apparatus (C9920-02G, Hamamatsu Photonics Co., Ltd. product), respectively.

From the measured quantum yield, the quantum yield ratio was calculated by the following formula (y).

Quantum yield ratio=Qf/Qs×100 (y)

[In formula (y), Qf represents the quantum yield of the cured film, and Qs represents the quantum yield of the quantum dot dilution dispersion.]

<Observation of luminescence color>

The UV lamp with a wavelength of 350 nm was irradiated to the obtained cured film under a dark room, and the light emission color of the cured film was observed visually.

<Remaining film rate evaluation>

After apply|coating a curable composition by the spin coating method on a 5 cm horizontal glass substrate (Eagle 2000, the Corning company make), it prebaked at 100 degreeC for 1 minute, and the composition layer was obtained. After cooling, the interval between the substrate on which the composition layer was formed and the quartz glass photomask was set to 100 μm, and the exposure machine (TME-150RSK, manufactured by Topcon Co., Ltd.) was used in an atmospheric atmosphere through the photomask, and 80 mJ/cm ^The composition layer was irradiated with light at an exposure dose of 2 (based on 365 nm). As a photomask, the thing in which the 100 micrometers line-and-space pattern was formed was used. The film thickness of the composition layer after light irradiation was measured with the film thickness measuring apparatus (DEKTAK3, Nippon Vacuum Technology Co., Ltd. product).

Next, the substrate on which the composition layer was formed after light irradiation was immersed in an aqueous developer solution (aqueous solution containing 0.12% nonionic surfactant and 0.04% potassium hydroxide) at 23° C. for 60 seconds to develop, followed by washing with water to obtain a cured pattern. The film thickness of the obtained cured pattern was measured with the film thickness measuring apparatus (DEKTAK3, Nippon Vacuum Technology Co., Ltd. product).

The residual film rate of the hardening pattern was calculated|required by Formula (z). It can be judged that the sensitivity of a curable composition is favorable as a residual-film rate is 90 % or more.

Remaining film ratio (%)=Td/Te×100 (z)

[In formula (z), Td represents the film thickness of the cured pattern, and Te represents the film thickness of the composition layer after light irradiation.]

Moreover, in the curable composition of a comparative example, since all the composition layers after light irradiation were dissolved in the developing solution, and the hardening pattern was not obtained on the board|substrate, the quantum yield ratio and luminescent color could not be observed.

ADVANTAGE OF THE INVENTION According to the curable composition of this invention, a cured pattern can be obtained with a high residual film rate at the time of image development, and the said cured pattern is excellent in the quantum yield when light-emitted.

Claims (7)

A curable composition comprising quantum dots, a polymerization initiator, a polymerizable compound, an alkali-soluble resin, and a leveling agent, wherein the polymerization initiator is at least one selected from the group consisting of an oxime compound, an acylphosphine compound, a triazine compound, and a biimidazole compound Including, wherein the alkali-soluble resin is at least one of the following resins [K2] to [K4],
Resin [K2]: a resin obtained by reacting (b) with the copolymer of (a) and (c);
Resin [K3]: a resin obtained by reacting (a) with the copolymer of (b) and (c);
Resin [K4]: a resin in which (a) is reacted with the copolymer of (b) and (c) and further reacted with carboxylic acid anhydride;
(Here, (a) is at least one selected from the group consisting of unsaturated carboxylic acid and unsaturated carboxylic acid anhydride, and (b) is a monomer having a cyclic ether structure having 2 to 4 carbon atoms and an ethylenically unsaturated bond, (c) is different from (a) and is a monomer copolymerizable with (a).)
curable composition. The method of claim 1,
A curable composition wherein at least one selected from the group consisting of an oxime compound, an acylphosphine compound, a triazine compound, and a biimidazole compound is a compound having at least two aromatic rings in the molecule. The method of claim 1,
The curable composition in which a polymerization initiator contains an oxime compound. The method of claim 1,
A curable composition comprising at least one selected from the group consisting of a quantum dot, a compound of a group 12 element and a group 16 element, a compound of a group 13 element and a group 15 element, and a compound of a group 14 element and a group 16 element. delete The cured film formed from the curable composition in any one of Claims 1-4. A display device comprising the cured film according to claim 6 .